Rituximab in the treatment of PLA2R-associated membranous nephropathy: insights from a hospital centre experience

被引：0
|
作者：
Henriques, Andreia Dos Santos [1 ]
Venda, Joao [1 ]
Ferreira, Emanuel [1 ]
Oliveira, Nuno [1 ]
Alves, Rui [1 ]
机构：
[1] Ctr Hosp & Univ Coimbra, Coimbra, Portugal
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.402
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
2154
引用
收藏
页数：1
相关论文
共 50 条
  • [21] IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report
    Huang, Meichun
    Liu, Jun
    Li, Xiuxiu
    OPEN LIFE SCIENCES, 2024, 19 (01):
  • [22] Clinicopathological Characteristics and Outcomes of PLA2R-Associated Membranous Nephropathy in Seropositive Patients Without PLA2R Staining on Kidney Biopsy
    Luo, Jiao
    Yuan, Ye
    Tian, Jianwei
    Zhou, Zhanmei
    Su, Cailing
    Yang, Fang
    Wang, Guobao
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 80 (03) : 364 - 372
  • [23] Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
    Teisseyre, Maxime
    Boyer-Suavet, Sonia
    Cremoni, Marion
    Brglez, Vesna
    Esnault, Vincent
    Seitz-Polski, Barbara
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (04): : 1183 - 1188
  • [24] Measurement of urinary exosomal phospholipase A2 receptor is a sensitive method for diagnosis of PLA2R-associated membranous nephropathy
    Wang, Bin
    Fu, Yu-Qi
    Xie, Li-jun
    Cao, Jin-Yuan
    Yang, Min
    Li, Min
    Chen, Tian-Lei
    Zhang, Xiao-Liang
    Luo, Qian
    Lv, Lin-Li
    Liu, Bi-Cheng
    CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
  • [25] Screening potential diagnostic biomarkers for PLA2R-associated idiopathic membranous nephropathy by WGCNA analysis and LASSO algorithm
    Huang, Jinxu
    Huang, Yaqing
    Zeng, Xiaoling
    Zhang, Yuhong
    Zhang, Junneng
    Hong, Qingchu
    Peng, Yongtiao
    RENAL FAILURE, 2025, 47 (01)
  • [26] Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab
    van de Logt, Anne-Els
    Dahan, Karine
    Rousseau, Alexandra
    van der Molen, Renate
    Debiec, Hanna
    Ronco, Pierre
    Wetzels, Jack
    KIDNEY INTERNATIONAL, 2018, 93 (04) : 1016 - 1017
  • [27] Pemphigus Vulgaris and PLA2R-Associated Membranous Nephropathy: Two IgG4-Related Diseases in the Same Patient
    Costa, Camila L.
    Correia, Matheus R.
    Sette, Luis H.
    Costa, Denise M.
    Oliveira, Camila B.
    Cavalcante, Maria Alina G.
    Maria Valente, Lucila
    Vajgel, Gisele
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 472 - 472
  • [28] RITUXIMAB FOR RELAPSING MEMBRANOUS NEPHROPATHY: A SPANISH HOSPITAL EXPERIENCE
    Fernandez Lorente, Loreto
    Manrique, Joaquin
    Teresa Visus, Maria
    Izquierdo, Diana
    Castano, Itziar
    Slon Roblero, Maria Fernanda
    Gomez, Nerea
    Romero, Gregorio
    Purroy Iruzun, Carolina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [29] A single-center, open label, randomized, controlled study of hydroxychloroquine sulfate in the treatment of low risk PLA2R-associated membranous nephropathy
    Mei, Mei
    Zeng, Jun
    Liu, Zhengyang
    Gong, Li
    Fang, Li
    Hu, Quan
    Huang, Shaofen
    Chai, Liyin
    Chen, Xinqing
    Sun, Haili
    Xiang, Sha
    Wen, Chaolin
    Shen, Bingbing
    BMC NEPHROLOGY, 2024, 25 (01)
  • [30] Efficacy and safety of rituximab in patients with PLA2R associated membranous nephropathy and resolved HCV infection
    Li, Xiaodan
    Song, Dongxu
    Hao, Yingxuan
    Ren, Mingjing
    Guo, Yanhong
    Zhao, Huayan
    Wang, Yulin
    Tang, Lin
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345